02 December 2024
SOLASTA Bio raises $14m, plans to commercialize peptide-based biopesticides in ‘half the time’ it takes for synthetics
UK-based ag biotech startup SOLASTA Bio has closed a $14 million oversubscribed Series A round, bringing its total funding to $19 million
SOLASTA Bio raises $14m for peptide-based biopesticides: SOLASTA Bio raises $14m, plans to commercialize peptide-based biopesticides in ‘half the time’ it takes for syntheticsMore articles
12 December 2025
New Ag International: SOLASTA Bio announces new peptide patents
“These patent grants represent a paradigm shift in crop protection, demonstrating that nature-inspired peptides can be effectively protected for commercial deployment,” says Shireen Davies, CEO and co-founder of SOLASTA Bio. “The ...
11 December 2025
SOLASTA Bio tightens IP grip as peptide bioinsecticides prove potent in global trials: Scottish Business News
'SOLASTA® Bio, a pioneering agri-biotech firm specialising in advanced green insecticides, has announced a significant expansion of its intellectual property portfolio and a series of robust field trial results. These ...